Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jgh van Roermund"'
Autor:
Rja Oomen, Joost L. Boormans, P J Ausems, S D Bos, Henk G. van der Poel, Henk B. Luiting, André N. Vis, Deric K E van der Schoot, Katja K.H. Aben, L Korsten, M A Noordzij, A van der West, T. van Doeveren, K J Lentjes, B P Schrier, P J Stelwagen, E L Koldewijn, M M Hobijn, Sytse C. van Beek, N van Ginkel, D M Somford, K T Buddingh, B.P. Wijsman, P van Zanten, Jakko A. Nieuwenhuijzen, H Bickerstaffe, K Dekker, M Braam, S Claus, S van der Meer, R I Nooter, O S Klaver, Jgh van Roermund, Smh Einerhand, A Lenting, Cpam Berger, M Jaspers-Valentijn, LA Grondhuis Palacios, D Baselmans, Tjn Hermans, H Roshani, T J Arends, Florentien J Hinsenveld, Ama Stroux, Caw Notenboom, M A van der Slot, A Berrens, J de Rooij, E J van Gennep, Lmcl Fossion, S H van Huystee, Wakm Windt
Publikováno v:
Urologic Oncology-Seminars and Original Investigations, 40, 60.e1-60.e9
Urologic Oncology: Seminars and Original Investigations. Elsevier Inc.
Urologic oncology-seminars and Original Investigations, 40(2), 60.e1-60.e9. Elsevier Science
Hinsenveld, F J, Boormans, J L, van der Poel, H G, van der Schoot, D K E, Vis, A N, Aben, K K H, Arends, T J, Ausems, P J, Baselmans, D, Berger, C P A M, Berrens, A, Bickerstaffe, H, Bos, S D, Braam, M, Buddingh, K T, Claus, S, Dekker, K, van Doeveren, T, Einerhand, S M H, Fossion, L M C L, van Gennep, E J, van Ginkel, N, Palacios, L A G, Hermans, T J N, Hobijn, M M, van Huystee, S H, Jaspers-Valentijn, M, Klaver, O S, Koldewijn, E L, On behalf of the Dutch Cystectomy Snapshot Group, Korsten, L, Lenting, A, Lentjes, K J, Luiting, H B, van der Meer, S, Nieuwenhuijzen, J A, Noordzij, M A, Nooter, R I, Notenboom, C A W, Oomen, R J A, van Roermund, J G H, de Rooij, J, Roshani, H, Schrier, B P, van der Slot, M A, Somford, D M, Stelwagen, P J, Stroux, A M A, van der West, A, Wijsman, B P, Windt, W A K M, van Zanten, P & van Beek, S C 2021, ' Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands ', Urologic Oncology: Seminars and Original Investigations . https://doi.org/10.1016/j.urolonc.2021.06.018
Urologic Oncology-Seminars and Original Investigations, 40, 2, pp. 60.e1-60.e9
Urologic Oncology: Seminars and Original Investigations, 40(2), 60.e1-60.e9. Elsevier Inc.
Urologic Oncology: Seminars and Original Investigations. Elsevier Inc.
Urologic oncology-seminars and Original Investigations, 40(2), 60.e1-60.e9. Elsevier Science
Hinsenveld, F J, Boormans, J L, van der Poel, H G, van der Schoot, D K E, Vis, A N, Aben, K K H, Arends, T J, Ausems, P J, Baselmans, D, Berger, C P A M, Berrens, A, Bickerstaffe, H, Bos, S D, Braam, M, Buddingh, K T, Claus, S, Dekker, K, van Doeveren, T, Einerhand, S M H, Fossion, L M C L, van Gennep, E J, van Ginkel, N, Palacios, L A G, Hermans, T J N, Hobijn, M M, van Huystee, S H, Jaspers-Valentijn, M, Klaver, O S, Koldewijn, E L, On behalf of the Dutch Cystectomy Snapshot Group, Korsten, L, Lenting, A, Lentjes, K J, Luiting, H B, van der Meer, S, Nieuwenhuijzen, J A, Noordzij, M A, Nooter, R I, Notenboom, C A W, Oomen, R J A, van Roermund, J G H, de Rooij, J, Roshani, H, Schrier, B P, van der Slot, M A, Somford, D M, Stelwagen, P J, Stroux, A M A, van der West, A, Wijsman, B P, Windt, W A K M, van Zanten, P & van Beek, S C 2021, ' Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands ', Urologic Oncology: Seminars and Original Investigations . https://doi.org/10.1016/j.urolonc.2021.06.018
Urologic Oncology-Seminars and Original Investigations, 40, 2, pp. 60.e1-60.e9
Urologic Oncology: Seminars and Original Investigations, 40(2), 60.e1-60.e9. Elsevier Inc.
BACKGROUND: Radical cystectomy with pelvic lymph node dissection is the recommended treatment in non-metastatic muscle-invasive bladder cancer (MIBC). In randomised trials, robot-assisted radical cystectomy (RARC) showed non-inferior short-term oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::271babd5374478c875b9eed3e1320aaf
https://doi.org/10.1016/j.urolonc.2021.06.018
https://doi.org/10.1016/j.urolonc.2021.06.018
Autor:
van Hoogstraten LMC; Netherlands Comprehensive Cancer Organisation, PO Box 1281, 6501 BG, Nijmegen, The Netherlands. l.vanhoogstraten@iknl.nl.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. l.vanhoogstraten@iknl.nl., Man CCO; Netherlands Comprehensive Cancer Organisation, PO Box 1281, 6501 BG, Nijmegen, The Netherlands., Witjes JA; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands., Meijer RP; Department of Oncological Urology, University Medical Centre Utrecht, Utrecht, The Netherlands., Mulder SF; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Smilde TJ; Department of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Ripping TM; Netherlands Comprehensive Cancer Organisation, PO Box 1281, 6501 BG, Nijmegen, The Netherlands., Kiemeney LA; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands., Aben KKH; Netherlands Comprehensive Cancer Organisation, PO Box 1281, 6501 BG, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publikováno v:
World journal of urology [World J Urol] 2023 Jul; Vol. 41 (7), pp. 1837-1845. Date of Electronic Publication: 2023 May 31.
Autor:
Walraven JEW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., Ripping TM; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., Oddens JR; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., van Rhijn BWG; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Goossens-Laan CA; Department of Urology, Alrijne Hospital, Leiderdorp, the Netherlands., Hulshof MCCM; Department of Radiotherapy, Amsterdam University Medical Centers, VU Medical Center, Amsterdam, the Netherlands., Kiemeney LA; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands., Lemmens VEPP; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., van der Hoeven JJM; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Verhoeven RHA; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Publikováno v:
BJU international [BJU Int] 2023 Feb; Vol. 131 (2), pp. 244-252. Date of Electronic Publication: 2022 Aug 05.
Autor:
Ripping TM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, PO Box 19079, 3501, DB, Utrecht, the Netherlands., Rammant E; King's College London, Faculty of Life Sciences & Medicine, Translational Oncology & Urology Research (TOUR), London, UK.; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands., Aaronson NK; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Hemelrijck M; King's College London, Faculty of Life Sciences & Medicine, Translational Oncology & Urology Research (TOUR), London, UK., van Hoogstraten LMC; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, PO Box 19079, 3501, DB, Utrecht, the Netherlands., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands., Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, PO Box 19079, 3501, DB, Utrecht, the Netherlands. k.aben@iknl.nl.; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands. k.aben@iknl.nl.
Publikováno v:
Health and quality of life outcomes [Health Qual Life Outcomes] 2022 Dec 29; Vol. 20 (1), pp. 171. Date of Electronic Publication: 2022 Dec 29.
Autor:
van Ginkel N; Department of Urology, Amsterdam University Medical Center, Location VUmc, De Boelelaan 1117, Postbus 7057, 1007 MB, Amsterdam, The Netherlands., Hermans TJN; Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Center, Location VUmc, De Boelelaan 1117, Postbus 7057, 1007 MB, Amsterdam, The Netherlands., Boormans JL; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands., Voortman J; Department of Medical Oncology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Mertens L; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Beek SC; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Center, Location VUmc, De Boelelaan 1117, Postbus 7057, 1007 MB, Amsterdam, The Netherlands. a.vis@amsterdamumc.nl.
Publikováno v:
International urology and nephrology [Int Urol Nephrol] 2022 Dec; Vol. 54 (12), pp. 3145-3152. Date of Electronic Publication: 2022 Aug 23.
Autor:
Sternberg CN; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Fizazi K; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Saad F; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Shore ND; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., De Giorgi U; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Penson DF; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Ferreira U; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Efstathiou E; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Madziarska K; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Kolinsky MP; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Cubero DIG; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Noerby B; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Zohren F; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Lin X; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Modelska K; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Sugg J; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Steinberg J; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois., Hussain M; From the Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); the University of Paris Saclay, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.), and Cross Cancer Institute, University of Alberta, Edmonton (M.P.K.) - both in Canada; the Carolina Urologic Research Center, Myrtle Beach, SC (N.D.S.); Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy (U.D.); Vanderbilt University, Nashville (D.F.P.); the State University of Campinas (Unicamp), Campinas (U.F.), and the ABC Foundation School of Medicine, Santo André (D.I.G.C.) - both in Brazil; M.D. Anderson Cancer Center, Houston (E.E.); Wroclaw Medical University, Wroclaw, Poland (K. Madziarska); Sygehus Lillebælt, Vejle, Denmark (B.N.); Pfizer, La Jolla (F.Z., X.L.), and Pfizer, San Francisco (K. Modelska) - both in California; and Astellas Pharma, Northbrook (J. Sugg, J. Steinberg), and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago (M.H.) - both in Illinois.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2020 Jun 04; Vol. 382 (23), pp. 2197-2206. Date of Electronic Publication: 2020 May 29.
Autor:
Ripping TM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands., Kiemeney LA; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands., van Hoogstraten LMC; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands., Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands., Aben KKH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands. katja.aben@radboudumc.nl.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. katja.aben@radboudumc.nl.
Publikováno v:
BMC cancer [BMC Cancer] 2020 May 20; Vol. 20 (1), pp. 455. Date of Electronic Publication: 2020 May 20.